Luregn Schlapbach is Associate Professor at University of Queensland and Senior Staff Specialist in the 36-bed multidisciplinary PICU at Lady Cilento Children`s Hospital in Brisbane, Australia. He is the theme leader for Sepsis, Infection&Inflammation at the Paediatric Critical Care Research Group (PCCRG), Mater Research Institute-UQ. He chairs the Paediatric Statewide Sepsis Collaborative in Queensland, Australia.
Luregn`s research has focused on sepsis and life-threatening infections in critically ill neonates and children, including aspects such as epidemiology, immunology, sepsis markers, outcomes and genomics in this highly vulnerable patient group. He is interested in improving our understanding of why some children become critically unwell because of infections, and in developing better approaches to allow early recognition and targeted treatment of sepsis and severe infections in children.
Luregn is ANZICS representative on the Pediatric Surviving Sepsis Campaign. He is involved in several international consortia on life-threatening childhood infections, the Swiss Pediatric Sepsis Study, and is in the steering board of several NHMRC funded trials.